GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,227,000 | -6.3% | 58,274 | -2.4% | 0.02% | -4.3% |
| Q2 2021 | $2,377,000 | -69.1% | 59,706 | -72.3% | 0.02% | -72.3% |
| Q1 2021 | $7,702,000 | +352.3% | 215,793 | +366.4% | 0.08% | -12.6% |
| Q4 2020 | $1,703,000 | +4.9% | 46,266 | +7.3% | 0.10% | +1.1% |
| Q3 2020 | $1,623,000 | +97.9% | 43,110 | +114.4% | 0.09% | +104.3% |
| Q2 2020 | $820,000 | +7.6% | 20,110 | 0.0% | 0.05% | +4.5% |
| Q1 2020 | $762,000 | -23.0% | 20,110 | -4.5% | 0.04% | +12.8% |
| Q4 2019 | $990,000 | -12.2% | 21,065 | -20.2% | 0.04% | -13.3% |
| Q3 2019 | $1,127,000 | +6.6% | 26,405 | 0.0% | 0.04% | +9.8% |
| Q2 2019 | $1,057,000 | +52.3% | 26,405 | +59.0% | 0.04% | +51.9% |
| Q1 2019 | $694,000 | -1.0% | 16,605 | -9.5% | 0.03% | -10.0% |
| Q4 2018 | $701,000 | -4.9% | 18,345 | 0.0% | 0.03% | +11.1% |
| Q3 2018 | $737,000 | +12.2% | 18,345 | +12.5% | 0.03% | +8.0% |
| Q2 2018 | $657,000 | +3.3% | 16,310 | +0.2% | 0.02% | +8.7% |
| Q1 2018 | $636,000 | +14.0% | 16,275 | +3.4% | 0.02% | +21.1% |
| Q4 2017 | $558,000 | -12.7% | 15,740 | 0.0% | 0.02% | -13.6% |
| Q3 2017 | $639,000 | -5.9% | 15,740 | 0.0% | 0.02% | -8.3% |
| Q2 2017 | $679,000 | -72.4% | 15,740 | -73.0% | 0.02% | -72.1% |
| Q1 2017 | $2,461,000 | +3.4% | 58,370 | -5.6% | 0.09% | +4.9% |
| Q4 2016 | $2,380,000 | -15.4% | 61,800 | -5.2% | 0.08% | -13.7% |
| Q3 2016 | $2,812,000 | +101.3% | 65,200 | +102.3% | 0.10% | +93.9% |
| Q2 2016 | $1,397,000 | +6.6% | 32,230 | -0.3% | 0.05% | +6.5% |
| Q1 2016 | $1,311,000 | +64.7% | 32,320 | +63.8% | 0.05% | +70.4% |
| Q4 2015 | $796,000 | +15.0% | 19,730 | +9.6% | 0.03% | +12.5% |
| Q3 2015 | $692,000 | -7.7% | 18,000 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $750,000 | +140.4% | 18,000 | +166.7% | 0.02% | +166.7% |
| Q1 2015 | $312,000 | +21.9% | 6,750 | +12.5% | 0.01% | +28.6% |
| Q4 2014 | $256,000 | – | 6,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |